Cunesoft Closes Funding

Cunesoft GmbH, a Munich, Germany-based provider of a cloud software provider for regulatory document and submission management, specialized in the pharmaceutical industry, closed an investment of undisclosed amount.

Backers included High-Tech Gründerfonds and Bayern Kapital.

The company intends to use the funds to further internationalize sales activities as well as to expand software’s capabilities.

Led by Rainer Schwarz, CEO, and Daniel Koppers, CTO, Cunesoft provides a SaaS-based regulatory solution for effective submission document preparation as well as eCTD (electronic Common Technical Document) drug submission publishing, specifically suited for small and medium-sized companies in the pharmaceutical industry including biotechnology companies, generic drug companies and pharma originators.



Join the discussion